JOSE ZEPEDA: Open Payments
NPI 1407218936 · EL CENTRO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,678 in 131 payments from 21 companies in 2025. Trend: 2023 $1,759 · 2024 $2,186 · 2025 $2,678
Food & beverage: $2,572Education: $106
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 12 | $426 |
| Amgen Inc. | 15 | $278 |
| Janssen Biotech, Inc. | 16 | $275 |
| ABBVIE INC. | 19 | $254 |
| AstraZeneca Pharmaceuticals LP | 10 | $211 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $202 |
| Mallinckrodt Hospital Products Inc. | 8 | $181 |
| ANI Pharmaceuticals, Inc. | 9 | $158 |
| PFIZER INC. | 6 | $147 |
| GlaxoSmithKline, LLC. | 4 | $87 |
Products named: Bimzelx, TREMFYA, ACTHAR, VRAYLAR, PURIFIED CORTROPHIN GEL, XELJANZ, ENBREL, KRYSTEXXA.
Industry payments across CA — which companies pay providers there.
